Eli Lilly and Company: Diabetes Mellitus, Type 2 trials
The registry lists 238 Diabetes Mellitus, Type 2 studies with Eli Lilly and Company as lead sponsor. 10 are open to participants now and 156 have results posted.
Phase 1 77Phase 2 37Phase 3 87Phase 4 33No phase 7(a study in two phases counts in both)
Studies
Page 2 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of LY2922470 in Healthy Participants and Participants With DiabetesCompletedNCT01746017Phase 1Results posted
- A Study of Dulaglutide in Chinese ParticipantsCompletedNCT01667900Phase 1Results posted
- A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT01648582Phase 3Results posted
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCompletedNCT01644500Phase 3Results posted
- A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesCompletedNCT01624259Phase 3Results posted
- A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
- The Effects of LY2409021 on the LiverCompletedNCT01588366Phase 1Results posted
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01584232Phase 3Results posted
- A Study of LY2605541 in Participants With Type 2 Diabetes MellitusCompletedNCT01582451Phase 3Results posted
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01558271Phase 3Results posted
- A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual SyringeCompletedNCT01524770Phase 1Results posted
- A First-in-Human Study of LY3009385 in Healthy ParticipantsCompletedNCT01477567Phase 1Results posted
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCompletedNCT01474538Phase 3Results posted
- A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01468987Phase 3Results posted
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01468181Phase 3Results posted
- A Study on the Effects of LY2409021 on the Electrical Impulses of the HeartCompletedNCT01460368Phase 1Results posted
- A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCompletedNCT01458210Phase 1Results posted
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy ParticipantsCompletedNCT01436201Phase 1Results posted
- A Study in Patients With Type 2 Diabetes MellitusCompletedNCT01435616Phase 3Results posted
- A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy ParticipantsCompletedNCT01432938Phase 1Results posted
- A Study in Adults With Type 2 DiabetesCompletedNCT01421459Phase 3Results posted
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 DiabetesCompletedNCT01408888Phase 1Results posted
- An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 DiabetesCompletedNCT01400971Results posted
- Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)CompletedNCT01394952Phase 3Results posted
- A Study of LY2881835 in Healthy People and People With DiabetesCompletedNCT01358981Phase 1Results posted
- A Study of the Effect of LY2189265 on Two Blood Pressure DrugsCompletedNCT01324388Phase 1Results posted
- A Study to Compare Two Forms of LY2608204 in Healthy PeopleCompletedNCT01313286Phase 1Results posted
- A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.CompletedNCT01301092Phase 1Results posted
- Effect of LY2189265 on Insulin Secretion in Response to Intravenous GlucoseCompletedNCT01300260Phase 1Results posted
- A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedNCT01253304Phase 1Results posted
- A Study of LY2608204 in Patients With Type 2 DiabetesCompletedNCT01247363Phase 1Results posted
- A Study of LY2409021 in Patients With Type 2 DiabetesCompletedNCT01241448Phase 2Results posted
- A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drink Leaves the Stomach in Patients With Type 2 Diabetes MellitusCompletedNCT01215968Phase 1Results posted
- Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 DiabetesCompletedNCT01215955Phase 4Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)CompletedNCT01191268Phase 3Results posted
- Comparison of the Efficacy and Safety of Two Insulin Intensification StrategiesCompletedNCT01175824Phase 4Results posted
- A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes MellitusCompletedNCT01175811Phase 4Results posted
- A Study of Postprandial Hyperglycemia in Participants With Type 2 DiabetesCompletedNCT01159938Phase 4Results posted
- A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCompletedNCT01149421Phase 2Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)CompletedNCT01126580Phase 3Results posted
- A Study in Participants With Diabetic Kidney DiseaseTerminatedNCT01113801Phase 2Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)CompletedNCT01075282Phase 3Results posted
- A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01064687Phase 3Results posted
- A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusTerminatedNCT01029795Phase 2Results posted
- A Study for Patients With Type 2 DiabetesCompletedNCT01027871Phase 2Results posted
- A Study of LY2599506 in Patients With Type 2 DiabetesTerminatedNCT01024244Phase 2Results posted
- A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
- A Study of Insulin Lispro Mix in Type 2 Diabetic Asian PatientsCompletedNCT00971997Phase 4Results posted
- A Study of LY2189102 in Patients With Type 2 DiabetesCompletedNCT00942188Phase 2Results posted
- A Study for Participants With Type 2 Diabetes MellitusCompletedNCT00871572Phase 2Results posted
- A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of DiabetesCompletedNCT00853151Phase 1Results posted
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00804986Phase 2Results posted
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesCompletedNCT00791479Phase 2Results posted
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminCompletedNCT00734474Phase 2/3Results posted
- A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsCompletedNCT00666718Phase 3Results posted
- Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light BreakfastCompletedNCT00664534Phase 4Results posted
- A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes MellitusCompletedNCT00630825Phase 2Results posted
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and ExenatideCompletedNCT00560417Phase 3Results posted
- A Study for Type 2 Diabetic PatientsCompletedNCT00548808Phase 4Results posted
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)CompletedNCT00510952Phase 3Results posted
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)CompletedNCT00494013Phase 3Results posted
- A Study for Patients With Diabetes Mellitus (IOPA)CompletedNCT00420095Phase 4Results posted
- Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)CompletedNCT00393705Phase 4Results posted
- Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)CompletedNCT00377858Phase 4Results posted
- The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)CompletedNCT00279201Phase 4Results posted
- Hyperglycemia and Cardiovascular Outcomes With Type 2 DiabetesCompletedNCT00191282Phase 4Results posted
- A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or ObesityActive, not recruitingNCT07438444Phase 4
- A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes MellitusCompletedNCT07313813Phase 1
- A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes MellitusActive, not recruitingNCT07299084Phase 1
- A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 DiabetesActive, not recruitingNCT07215559Phase 2
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal InsulinActive, not recruitingNCT07215312Phase 2
- A Study of LY3549492 in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT07073170Phase 1
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 DiabetesActive, not recruitingNCT06993792Phase 3
- A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to HypoglycemiaCompletedNCT06982846Phase 1
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 DiabetesActive, not recruitingNCT06972472Phase 3
- A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 DiabetesCompletedNCT06945419Phase 1
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 DiabetesWithdrawnNCT06901349Phase 2
- A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsCompletedNCT06869018Phase 1
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During RamadanCompletedNCT06635057Phase 4
- A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 DiabetesCompletedNCT06603571Phase 2
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Active, not recruitingNCT06383390Phase 3
- A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes MellitusCompletedNCT06362265Phase 1
- Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)CompletedNCT06354660Phase 3
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)Active, not recruitingNCT06297603Phase 3
- Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)Active, not recruitingNCT06260722Phase 3
- A Multiple Dose Study of LY3209590 in Participants With Type 2 DiabetesCompletedNCT06169982Phase 1
- A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusCompletedNCT06132126Phase 1
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityActive, not recruitingNCT06037252Phase 2
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightCompletedNCT05929079Phase 3
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskCompletedNCT05803421Phase 3
- A Study of LY3209590 in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT05596747Phase 1
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05536804Phase 2
- A Study of LY3532226 in Participants With Type 2 Diabetes MellitusCompletedNCT05407961Phase 1
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 DiabetesCompletedNCT05377333Phase 1
- A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT05327595Phase 1
- A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes MellitusCompletedNCT04957914Phase 1
- A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 DiabetesWithdrawnNCT04864977Phase 4
- A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT04823208Phase 1
- A Study of Glucose Control in Participants With Type 1 and Type 2 DiabetesWithdrawnNCT04667182
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT04641312Phase 1